David H. Koch Center for Cancer Care at Memorial Sloan Kettering

New York, New York 10021

1 studies enrolling now · 2 studies all time

What they study most

Chronic Myeloid Leukemia, Chronic Phase, Chronic Phase Chronic Myeloid Leukemia, PET-MF, PMF, PPV-MF, Post-Essential Thrombocythemia Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Primary Myelofibrosis

Studies at this site

• A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i) — Recruiting now
• Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors — Running, not enrolling